Mark Leonard Singleton - 14 Mar 2025 Form 4 Insider Report for Bioventus Inc. (BVS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
17 Mar 2026, 17:03:39 UTC
Prior SEC filing
20 Feb 2025
Next SEC filing
21 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Anthony D'Adamio, Attorney-in-Fact

Key filing fact

Mark Leonard Singleton filed Form 4 for Bioventus Inc. (BVS) on 17 Mar 2026.

Key facts

  • This page summarizes Mark Leonard Singleton's Form 4 filing for Bioventus Inc. (BVS).
  • 7 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 17 Mar 2026, 17:03.

Change

  • Previous filing in this sequence was filed on 20 Feb 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001914936 Primary reporting owner

Singleton Mark Leonard

Relationship
SVP & CFO
Address
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
Signature
/s/ Anthony D'Adamio, Attorney-in-Fact
Signature date
17 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BVS transaction

Class A Common Stock

Options Exercise

Transaction value
Shares
+13,500
Change %
+8.9%
Price
$0.000000*
Shares after
165,312
Date
13 Mar 2026
Ownership
Direct
BVS transaction

Class A Common Stock

Tax liability

Transaction value
Shares
-5,865
Change %
-3.5%
Price
$8.62*
Shares after
159,447
Date
13 Mar 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BVS transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares
+54,000
Change %
Price
$0.000000*
Shares after
54,000
Date
14 Mar 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
54,000
Exercise price
Footnotes
F1, F2
BVS transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+61,000
Change %
Price
$0.000000*
Shares after
61,000
Date
14 Mar 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
61,000
Exercise price
$9.61
Footnotes
F2
BVS transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares
+104,000
Change %
Price
$0.000000*
Shares after
104,000
Date
13 Mar 2026
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
104,000
Exercise price
Footnotes
F1, F3
BVS transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+116,000
Change %
Price
$0.000000*
Shares after
116,000
Date
13 Mar 2026
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
116,000
Exercise price
$8.62
Footnotes
F3
BVS transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-13,500
Change %
-25%
Price
$0.000000*
Shares after
40,500
Date
13 Mar 2026
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
13,500
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.

Footnote F2

The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date.

Footnote F3

The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2026, in each case subject to the Reporting Person continuing in service through the applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .